Encompass Health Corporation (EHC) Stock
Key stats
- Market cap
- $13.96B
- Price / Earnings ratio
- 21.7x
- EPS (TTM)
- $6.48
- Volume
- Loading
- 52-week high
- $143.36
- 52-week low
- $92.77
- Dividend yield
- 0.55%
- Dividend amount (latest)
- $0.19
- EPS vs analyst estimate
- +3.4%Q3 FY25 · $1.23 vs $1.19
Source: third-party data provider, as of November 13, 2026
EPS estimate: analyst consensus
Compare with EHC
Recent news

Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know
Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know
EHC

Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
EHC

Here's Why Encompass Health (EHC) is a Strong Value Stock
Here's Why Encompass Health (EHC) is a Strong Value Stock
EHC

Encompass Health Q3 Earnings Call Highlights
Encompass Health Q3 Earnings Call Highlights
EHC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 68.12
- MACD 12/26/9
- 5.02
- EMA 9 of MACD
- 3.76
- MACD histogram
- 1.26
- SMA 50
- $125.91
- Price above SMA 50
- EMA 50
- $127.23
- Price above EMA 50
- SMA 200
- $111.68
- Price above SMA 200
- EMA 200
- $114.86
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.36 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know
Encompass Health (EHC) Is Up 9.52% in One Week: What You Should Know
EHC

Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
Encompass Health Corporation (EHC) Hits Fresh High: Is There Still Room to Run?
EHC

Here's Why Encompass Health (EHC) is a Strong Value Stock
Here's Why Encompass Health (EHC) is a Strong Value Stock
EHC

Encompass Health Q3 Earnings Call Highlights
Encompass Health Q3 Earnings Call Highlights
EHC

Encompass Health (EHC) Reports Q3 Earnings: What Key Metrics Have to Say
Encompass Health (EHC) Reports Q3 Earnings: What Key Metrics Have to Say
EHC

Encompass Health (EHC) Q3 Earnings and Revenues Top Estimates
Encompass Health (EHC) Q3 Earnings and Revenues Top Estimates
EHC

Here's Why Encompass Health (EHC) is a Strong Momentum Stock
Here's Why Encompass Health (EHC) is a Strong Momentum Stock
EHC

Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
Encompass Health (EHC) is a Top-Ranked Growth Stock: Should You Buy?
EHC

Are Investors Undervaluing Encompass Health (EHC) Right Now?
Are Investors Undervaluing Encompass Health (EHC) Right Now?
EHC

Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
EHC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Encompass Health Corporation
Encompass Health Corp. engages in the provision of post-acute healthcare services. It provides specialized rehabilitative treatment on an inpatient basis. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Mark J. Tarr | CEO, President & Director | 1962 |
| Mr. Douglas E. Coltharp | Executive VP & CFO | 1962 |
| Mr. Patrick W. Tuer | Executive VP & COO | 1985 |
| Mr. John Patrick Darby | Executive VP, General Counsel & Corporate Secretary | 1965 |
| Dr. Elissa Joy Charbonneau D.O., M.S. | Chief Medical Officer | 1960 |
| Mr. Andrew L. Price | Senior VP & Chief Accounting Officer | 1967 |
| Mr. Rusty Yeager | Chief Information Officer & Senior VP | — |
| Mr. Mark Miller | Senior Vice President of Investor Relations & Strategic Planning | — |
| Ms. Dawn Rock | Chief Compliance Officer | — |
| Mr. Anthony A. Hernandez | Chief Human Resources Officer | 1966 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 68.12
- MACD 12/26/9
- 5.02
- EMA 9 of MACD
- 3.76
- MACD histogram
- 1.26
- SMA 50
- $125.91
- Price above SMA 50
- EMA 50
- $127.23
- Price above EMA 50
- SMA 200
- $111.68
- Price above SMA 200
- EMA 200
- $114.86
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
5 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $150.00
- Average
- $154.40
- High
- $165.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -8.2 | +15.3 | ||||||||||
| 2022 | -7.2 | +7.4 | +7.1 | -3.9 | -4.0 | -13.3 | +8.8 | -4.2 | -7.1 | +15.8 | +6.0 | +3.5 |
| 2023 | +5.0 | -10.6 | -3.8 | +18.6 | -3.5 | +8.7 | -1.7 | +7.7 | -5.4 | -6.1 | +4.2 | +0.5 |
| 2024 | +5.8 | +1.9 | +11.3 | +0.2 | +4.2 | +2.6 | +8.9 | +0.0 | +3.6 | +3.9 | +4.1 | -9.8 |
| 2025 | +8.1 | -0.4 | +1.5 | +15.5 | +4.3 | +1.5 | -8.6 | +12.2 | +2.7 | -8.6 | +0.1 | -7.5 |
| 2026 | -11.1 | +15.0 | -10.5 | +2.7 | -1.5 | -1.6 | +9.5 | +6.9 | -0.5 | +14.1 | +3.7 |



